new york/milan LLC

3727 buchanan street
san francisco, california 94123

NYS Entity Status
ACTIVE

NYS Filing Date
DECEMBER 24, 2013

NYS DOS ID#
4505204

County
NEW YORK

Jurisdiction
DELAWARE

Registered Agent
NONE

NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY

Name History
2013 - NEW YORK/MILAN LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Three things we learned: SF Deltas vs. NY Cosmos
    By Douglas Zimmerman - Tuesday Aug 8, 2017

    After falling behind the New York Cosmos, San Francisco responded with two goals to win their first home game of the fall season. Here are three things we learned from the game: 1) The team responded well to the loss of Cristian Portilla A day before the Cosmos game the team learned they would be

    Source: SFGATE.com: The Beautiful Blog - SF soccer
  • SF Deltas overcome early goal to beat NY Cosmos 2-1
    By Douglas Zimmerman - Sunday Aug 6, 2017

    The second largest crowd in San Francisco Deltas early history saw the home team overcome an early goal to pull out a 2-1 victory over the defending champions New York Cosmos. 3,369 fans were treated to a 36th minute tying goal by Deltas defender Patrick Hopkins and a penalty kick by Tommy Heinemann to complete

    Source: SFGATE.com: The Beautiful Blog - SF soccer
  • IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
    By Ben Fidler - Thursday Aug 3, 2017

    Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]

    Source: Xconomy New York
  • For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
    By Ben Fidler - Wednesday Aug 9, 2017

    A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]

    Source: Xconomy New York
new yorkmilan llc san francisco ny